Cargando…

Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma

High mobility group box 1 (HMGB1) and HMGB2 overexpression has been observed in several human tumor types, and is involved in cancer progression and prognosis. However, the clinicopathological significance of HMGB1 and HMGB2 expression in bladder carcinoma (BCa), particularly the involvement of thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, WEI, JIANG, HAOWEN, ZHU, HECHEN, ZHANG, HU, GONG, JIAN, ZHANG, LIMIN, DING, QIANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576183/ https://www.ncbi.nlm.nih.gov/pubmed/23426143 http://dx.doi.org/10.3892/ol.2012.1091

Ejemplares similares

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
por: Huang, Changkun, et al.
Publicado: (2018)

Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma
por: Zhu, Lingyin, et al.
Publicado: (2015)

High‐mobility group box‐1 contributes tumor angiogenesis under interleukin‐8 mediation during gastric cancer progression
por: Chung, Hye Won, et al.
Publicado: (2017)

The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2015)

Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4
por: Ma, Fei, et al.
Publicado: (2017)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1
por: Kouzoukas, Dimitrios E., et al.
Publicado: (2016)

High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis
por: Zhang, Qiang-Bo, et al.
Publicado: (2016)

High mobility group box 2 modulates the progression of osteosarcoma and is related with poor prognosis
por: Yang, Shicong, et al.
Publicado: (2020)

Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
por: Liu, Jian-Ye, et al.
Publicado: (2013)

Retraction Note: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2018)

High mobility group box 1 promotes radioresistance in esophageal squamous cell carcinoma cell lines by modulating autophagy
por: Ma, Hongbing, et al.
Publicado: (2019)

Impact of high-mobility-group A2 overexpression on epithelial-mesenchymal transition in pancreatic cancer
por: Gong, Jian, et al.
Publicado: (2019)

Clinical and prognostic significance of high-mobility group box-1 in human gliomas
por: WANG, XIN-JUN, et al.
Publicado: (2015)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Overexpression of Receptor for Advanced Glycation End Products and High-Mobility Group Box 1 in Human Dental Pulp Inflammation
por: Tancharoen, Salunya, et al.
Publicado: (2014)

Relationship between high-mobility group box 1 overexpression in ovarian cancer tissue and serum: a meta-analysis
por: Wang, Haipeng, et al.
Publicado: (2015)

Ureteral reconstruction using a tapered non-vascularized bladder graft: an experimental study in a canine animal model
por: Zou, Lujia, et al.
Publicado: (2017)

High-Mobility Group Box-1-Induced Angiogenesis After Indirect Bypass Surgery in a Chronic Cerebral Hypoperfusion Model
por: Nishihiro, Shingo, et al.
Publicado: (2019)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

Role of high-mobility group box 1 in methamphetamine-induced activation and migration of astrocytes
por: Zhang, Yuan, et al.
Publicado: (2015)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway
por: Li, Shu, et al.
Publicado: (2023)

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2018)

Overexpression of High-Mobility Motor Box 1 in the Blood and Tissues of Patients with Head and Neck Squamous Cell Carcinoma
por: Mohajertehran, Farnaz, et al.
Publicado: (2018)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

NLRP3 Inflammasome-Dependent Increases in High Mobility Group Box 1 Involved in the Cognitive Dysfunction Caused by Tau-Overexpression
por: Zhao, Yan, et al.
Publicado: (2021)

The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population
por: Liu, Shenghua, et al.
Publicado: (2015)

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury
por: Gou, Xiaoyun, et al.
Publicado: (2020)

Helicobacter hepaticus Infection Promotes the Progression of Liver Preneoplasia in BALB/c Mice via the Activation and Accumulation of High-Mobility Group Box-1
por: Cao, Shuyang, et al.
Publicado: (2022)

Developmental expression of high-mobility group box 1 (HMGB1) in the mouse cochlea
por: Liu, Wenjing, et al.
Publicado: (2023)

Vagal modulation of high mobility group box-1 protein mediates electroacupuncture-induced cardioprotection in ischemia-reperfusion injury
por: Zhang, Juan, et al.
Publicado: (2015)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

The role of high mobility group box 1 protein in acute cerebrovascular diseases
por: Mu, Shu-Wen, et al.
Publicado: (2018)

ADAR1 overexpression is associated with cervical cancer progression and angiogenesis
por: Chen, Ying, et al.
Publicado: (2017)

High mobility group box-1 and its clinical value in breast cancer
por: Sun, Shanping, et al.
Publicado: (2015)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0ruiqms227tcuvfugai4ssa7t9